PD-1-PD-1 ligand interaction contributes to immunosuppressive microenvironment of Hodgkin lymphoma - PubMed
- ️Tue Jan 01 2008
. 2008 Mar 15;111(6):3220-4.
doi: 10.1182/blood-2007-05-085159. Epub 2008 Jan 18.
Affiliations
- PMID: 18203952
- DOI: 10.1182/blood-2007-05-085159
Free article
PD-1-PD-1 ligand interaction contributes to immunosuppressive microenvironment of Hodgkin lymphoma
Ryo Yamamoto et al. Blood. 2008.
Free article
Abstract
Programmed death-1 (PD-1)-PD-1 ligand (PD-L) signaling system is involved in the functional impairment of T cells such as in chronic viral infection or tumor immune evasion. We examined PD-L expression in lymphoid cell lines and found that they were up-regulated on Hodgkin lymphoma (HL) and several T-cell lymphomas but not on B-cell lymphomas. PD-L expression was also demonstrated in primary Hodgkin/Reed-Sternberg (H/RS) cells. On the other hand, PD-1 was elevated markedly in tumor-infiltrating T cells of HL, and was high in the peripheral T cells of HL patients as well. Blockade of the PD-1 signaling pathway inhibited SHP-2 phosphorylation and restored the IFN-gamma-producing function of HL-infiltrating T cells. According to these results, deficient cellular immunity observed in HL patients can be explained by "T-cell exhaustion," which is led by the activation of PD-1-PD-L signaling pathway. Our finding provides a potentially effective immunologic strategy for the treatment of HL.
Similar articles
-
Expression of the Immune Checkpoint Regulators LAG-3 and TIM-3 in Classical Hodgkin Lymphoma.
El Halabi L, Adam J, Gravelle P, Marty V, Danu A, Lazarovici J, Ribrag V, Bosq J, Camara-Clayette V, Laurent C, Ghez D. El Halabi L, et al. Clin Lymphoma Myeloma Leuk. 2021 Apr;21(4):257-266.e3. doi: 10.1016/j.clml.2020.11.009. Epub 2020 Nov 12. Clin Lymphoma Myeloma Leuk. 2021. PMID: 33277223
-
Challenges and perspectives in the immunotherapy of Hodgkin lymphoma.
Michot JM, Lazarovici J, Ghez D, Danu A, Fermé C, Bigorgne A, Ribrag V, Marabelle A, Aspeslagh S. Michot JM, et al. Eur J Cancer. 2017 Nov;85:67-77. doi: 10.1016/j.ejca.2017.08.014. Epub 2017 Sep 9. Eur J Cancer. 2017. PMID: 28892775 Review.
-
Jalali S, Price-Troska T, Bothun C, Villasboas J, Kim HJ, Yang ZZ, Novak AJ, Dong H, Ansell SM. Jalali S, et al. Blood Cancer J. 2019 Feb 19;9(3):22. doi: 10.1038/s41408-019-0185-9. Blood Cancer J. 2019. PMID: 30783096 Free PMC article.
-
Xie W, Medeiros LJ, Li S, Yin CC, Khoury JD, Xu J. Xie W, et al. Curr Hematol Malig Rep. 2020 Aug;15(4):372-381. doi: 10.1007/s11899-020-00589-y. Curr Hematol Malig Rep. 2020. PMID: 32394185 Review.
-
Villasboas JC, Ansell S. Villasboas JC, et al. Cancer J. 2016 Jan-Feb;22(1):17-22. doi: 10.1097/PPO.0000000000000164. Cancer J. 2016. PMID: 26841012 Review.
Cited by
-
T cell metabolic fitness in antitumor immunity.
Siska PJ, Rathmell JC. Siska PJ, et al. Trends Immunol. 2015 Apr;36(4):257-64. doi: 10.1016/j.it.2015.02.007. Epub 2015 Mar 12. Trends Immunol. 2015. PMID: 25773310 Free PMC article. Review.
-
Antibody therapy of pediatric B-cell lymphoma.
Meyer-Wentrup F, de Zwart V, Bierings M. Meyer-Wentrup F, et al. Front Oncol. 2013 Apr 2;3:68. doi: 10.3389/fonc.2013.00068. eCollection 2013. Front Oncol. 2013. PMID: 23565504 Free PMC article.
-
Lin CC, Curigliano G, Santoro A, Kim DW, Tai D, Hodi FS, Wilgenhof S, Doi T, Sabatos-Peyton C, Szpakowski S, Chitnis S, Xyrafas A, Gutzwiller S, Pastore A, Mach N. Lin CC, et al. BMJ Open. 2024 Aug 29;14(8):e079132. doi: 10.1136/bmjopen-2023-079132. BMJ Open. 2024. PMID: 39209782 Free PMC article. Clinical Trial.
-
Yamamoto R, Nishikori M, Tashima M, Sakai T, Ichinohe T, Takaori-Kondo A, Ohmori K, Uchiyama T. Yamamoto R, et al. Cancer Sci. 2009 Nov;100(11):2093-100. doi: 10.1111/j.1349-7006.2009.01302.x. Epub 2009 Aug 1. Cancer Sci. 2009. PMID: 19703193 Free PMC article.
-
Song X, Chen Q, Wang J, Mao Q, Xia W, Xu L, Jiang F, Dong G. Song X, et al. J Cell Mol Med. 2022 Jan;26(2):436-448. doi: 10.1111/jcmm.17097. Epub 2021 Dec 8. J Cell Mol Med. 2022. PMID: 34877770 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials